ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #5,479Gold OA

Aids Research and Therapy

Acronym:arty
•
Abbreviation (ISO):AIDS RES THER
•
Identifier (ISSN):1742-6405(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
2.8↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Aids Research and Therapy

WoS Q2
12342.3620182.2420192.0920202.2520212.8520222.220232.120242.520252.82026
Annual Impact Factor Metric
Current (2026):2.8
Scopus SJR & RankScopus Q2
0.934
#5,479

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
54

54 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate4.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
99articles/year
100% Gold OA•85.29% Original Research

Aims & Scope

AIDS Research and Therapy publishes articles on basic science, translational, clinical, social, epidemiological, behavioral and educational sciences articles focused on the treatment and prevention of HIV/AIDS, and the search for the cure. The Journal publishes articles on novel and developing treatment strategies for AIDS as well as on the outcomes of established treatment strategies. Original research articles on animal models that form an essential part of the AIDS treatment research are also considered

Topics Covered (Recognized by AI)
Medicine99.2%Biology94.8%Immunology88%Virology83.7%Family medicine82.4%Human immunodeficiency virus (HIV)79.6%Internal medicine78.6%Genetics69.3%Pathology64.8%Virus54.8%Viral load44.7%Mathematics41.9%Statistics38.9%Antiretroviral therapy38.8%Chemistry36.2%Biochemistry34.4%Sociology33.3%Surgery33.1%Demography29.4%Psychology28.5%Computer science25.5%Environmental health25%Psychiatry24.5%Population20.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

INFECTIOUS DISEASES

Q2
Rank67/141
IndexSCIE
JCISCIE2026

INFECTIOUS DISEASES

Q3
Rank71/141
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.8
Articles / Year108
Total Citations16
2025
IF2.5
Articles / Year141
Total Citations327
2024
IF2.1
Articles / Year102
Total Citations478
2023
IF2.2
Articles / Year91
Total Citations985
2022
IF2.846
Articles / Year69
Total Citations1,033

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,479Scopus Q2SCImago Profile
Scopus Coverage:2004-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
0.934

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.62

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,240 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations735
3-Year Documents255
Citable Documents254

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Molecular MedicineQ2
Pharmacology (medical)Q2
VirologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区INFECTIOUS DISEASES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Aids Research and Therapy (acronym: arty, abbr: AIDS RES THER, ISSN: 1742-6405) is a peer-reviewed international scholarly journal in the field of INFECTIOUS DISEASES, published by BioMed Central in England since 2004. The periodical holds a Journal Impact Factor (JIF) of 2.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.934 (Q2), an H-index of 54.

The journal enforces rigorous peer evaluation with an annual output of approximately 99 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,240 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Periodic
Founding Year
2004
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7359ce82-dc64-446f-88a4-f89d4390ecf8
Database Updated: 2026-10-01